PUBLIC CONTRACT · 2018
61051518 - Aq urgente medicamentos
- Contract value
- €42,479.01
- Signed on
- 4 December 2018
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 5038863PUBLISHED SUBJECT
Ibrutinib 140 mg Cáps Nilotinib 200 mg Cáps Ruxolitinib 20 mg Comp Sorafenib 200 mg Comp
Parties involved
- Place of performance
- Portugal, Setúbal, Setúbal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- NOVARTIS FARMA-PRODUT.FARMACEUTICOS, SA · Tax ID 500063524
- Awardee
- JANSSEN-CILAG FARMACEUTICA LDA · Tax ID 500189412
- Awardee
- BAYER PORTUGAL, SA. · Tax ID 500043256
Values and timeline
- Contract price
- €42,479.01
- Procedure base price
- €42,479.01
- Total effective price
- Not reported on Portal BASE
- Publication date
- 13 December 2018
- Award date
- 4 December 2018
- Signing date
- 4 December 2018
- Performance period
- 10 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Preço ou custo
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2017/61 - Acordo quadro para fornecimento de Medicamentos Diversos às Instituições e Serviços do Serviço Nacional de Saúde
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 3729477
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.